School of Medicine & Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
GP Synergy NSW and ACT Research and Evaluation Unit, Newcastle, New South Wales, Australia.
Aust N Z J Obstet Gynaecol. 2021 Jun;61(3):469-473. doi: 10.1111/ajo.13320. Epub 2021 Feb 15.
Long-acting reversible contraception (LARC) is highly effective but uptake in Australia is low. We aimed to establish general practitioner (GP) registrars' (vocational trainees') perspectives on barriers to prescribing LARC. We conducted a cross-sectional questionnaire-based study of 191 GP registrars in NSW and ACT. Outcome factors were levels of agreement with eight barriers to prescribing LARC. We found the most-reported barriers to prescribing LARC were limited access to training and limited opportunities to maintain skills. Registrars perceived greater barriers to the use of intrauterine devices, compared to contraceptive implants, regarding indemnity insurance, difficulty accessing training, and insufficient insertion opportunities to maintain skills.
长效可逆避孕（LARC）具有高度有效性，但在澳大利亚的使用率较低。我们旨在确定全科医生（GP）注册医师（职业培训生）在开 LARC 方面的障碍。我们对新南威尔士州和首都领地的 191 名 GP 注册医师进行了一项横断面基于问卷的研究。结果因素是对开 LARC 的八种障碍的同意程度。我们发现，在培训机会有限和维持技能的机会有限方面，开 LARC 的最常见障碍是有限的。与避孕植入物相比，注册医师认为在保险、获取培训的难度和维持技能的插入机会不足等方面，宫内节育器的使用存在更大的障碍。
